Cited by 119Cardiovascular Syncope and Autonomic DisordersHeart Failure Treatment and ManagementCardiac pacing and defibrillation studies

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Syncope Predicts the Outcome of Cardiomyopathy Patients

Open access

Abstract

Objectives The outcome of congestive heart failure (CHF) patients with syncope is understood incompletely.Background We analyzed data from patients enrolled in the SCD-HeFT (Sudden Cardiac Death Heart Failure Trial) to determine whether syncope predicted outcomes in patients with CHF.Methods We compared outcomes (and associated clinical characteristics) in patients with and without syncope enrolled in SCD-HeFT.Results In SCD-HeFT, 162 (6%) patients had syncope before randomization, 356 (14%) had syncope after randomization (similar incidence in each randomized arm), and 46 (2%) had syncope before and after randomization. A QRS duration >or=120 ms and absence of beta-blocker use predicted syncope during follow-up (hazard ratio [HR] 1.30 and 95% confidence interval [CI] 1.06 to 1.61, p = 0.014 and HR 1.25, 95% CI 1.01 to 1.56, p = 0.048, respectively). Syncope recurrence did not differ by randomization arm. However, in the implantable cardioverter-defibrillator (ICD) arm, syncope, before and after randomization, was associated with appropriate ICD discharges (HR 1.75, 95% CI 1.10 to 2.80, p = 0.019 and HR 2.91, 95% CI 1.89 to 4.47, p = 0.001, respectively). Post-randomization syncope predicted total and cardiovascular death (HR 1.41, 95% CI 1.13 to 1.76, p = 0.002 and HR 1.55, 95% CI 1.19 to 2.02, p = 0.001, respectively). The elevated relative risk of mortality for syncope versus non-syncope patients did not vary significantly across treatment arms (ICD, HR 1.54, 95% CI 1.04 to 2.27; amiodarone, HR 1.33, 95% CI 0.91 to 1.93; and placebo, HR 1.39, 95% CI 0.96 to 2.02, test for difference p = 0.86).Conclusions For CHF patients with ICDs, syncope was associated with appropriate ICD activations. Syncope was associated with increased mortality risk in SCD-HeFT regardless of treatment arm (placebo, amiodarone, or ICD).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2007.11.065

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Research works printed but not linked: 2

  1. Racco, 2000, Long-term follow-up after syncope, Minerva Cardioangiol, 48, 69
  2. Poole, 2004, Analysis of implantable defibrillator shock electrograms in the Sudden Cardiac Death-Heart Failure Trial, Heart Rhythm, 1, S178

Cited by

Sorted by citations

Metadata

Authors
Olshansky, B., Poole, J. E., Johnson, G., Anderson, J., Hellkamp, A. S., Packer, D., Mark, D. B., Lee, K. L., & Bardy, G. H.
Affiliations
  • University of Iowa (US)
  • University of Washington (US)
  • The Seattle Institute for Cardiac Research (US)
  • Duke University (US)
  • Mayo Clinic (US)
Corresponding author
Olshansky, Brian
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2008-04
Volume
51
Issue
13
Pages
1277-1282
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2135351378
Cited by
119
References
32
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 1 · 2018: 11 · 2017: 20 · 2016: 2 · 2015: 9 · 2014: 7 · 2013: 14 · 2012: 8
FWCI
10.19
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • Medtronic
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Syncope and Autonomic Disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Keywords
syncope, congestive heart failure, cardiomyopathy, SCD-HeFT trial, implantable cardioverter-defibrillator, mortality prediction, QRS duration, beta-blocker therapy, amiodarone, sudden cardiac death, syncope recurrence, prognostic factors, cardiovascular mortality, arrhythmic risk stratification, heart failure with reduced ejection fraction
MeSH terms
Adult, Amiodarone, Anti-Arrhythmia Agents, Female, Health Status, Heart Failure, Humans, Male, Middle Aged, Cardiomyopathies, Predictive Value of Tests, Prognosis, Recurrence, Risk, Risk Factors, Stroke Volume, Syncope, Time Factors, Death, Sudden, Cardiac, Treatment Outcome, Defibrillators, Implantable, Myocardial Ischemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review